Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2003

Komdeur Rudy, Hoekstra Harald J, Molenaar Willemina M, Van Den Berg Eva, Zwart Nynke, Pras Elisabeth, Plaza-Menacho Iwan, Hofstra Robert M W, Van Der Graaf Winette T A

Abstract excerpt

PURPOSE: Postradiation sarcoma, a sarcoma developing in a previously irradiated field, is a rare tumor. Surgery appears to be the only curative treatment option. In general the prognosis is poor, and new treatments options are needed. One study reported the expression of KIT receptor tyrosine kin...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dose-Response Relationship, Radiation
Share to Hemangiosarcoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Neoplasms, Radiation-Induced

Share to Proto-Oncogene Proteins c-kit

Share to Radiotherapy

Share to Sarcoma

Share to Soft Tissue Neoplasms

Source

Identifiers

PMID: 12912938

Genes

KIT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12912938-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target.PMID 12912938Read ↗

Consistent <i>MYC</i> and <i>FLT4</i> gene amplification in radiation‐induced angiosarcoma but not in other radiation‐associated atypical vascular lesionsSemantic proximity Read ↗

The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation‐associated angiosarcomas of the breastSemantic proximity Read ↗

Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.Semantic proximity Read ↗

Sustained response to imatinib in patient with extraskeletal myxoid chondrosarcoma and novel KIT mutation.Semantic proximity Read ↗

Clinicopathologic and molecular correlates to neoadjuvant chemotherapy-induced pathologic response in breast angiosarcoma.Semantic proximity Read ↗

Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.Semantic proximity Read ↗

KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.Semantic proximity Read ↗

Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long-term follow-up and literature review.Semantic proximity Read ↗

Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.Semantic proximity Read ↗

Post-irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review.Semantic proximity Read ↗

Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.Semantic proximity Read ↗

KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.